Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides

IF 6.8 1区 医学 Q1 CHEMISTRY, MEDICINAL Journal of Medicinal Chemistry Pub Date : 2024-10-09 DOI:10.1021/acs.jmedchem.4c0117910.1021/acs.jmedchem.4c01179
Zufang Ba, Yu Wang, Yinyin Yang, Bingqian Ren, Beibei Li, Xu Ouyang, Jingying Zhang, Tingting Yang, Yao Liu, Yuhuan Zhao, Ping Yang, Xiaoyan Wu, Wenbo Mao, Chao Zhong, Hui Liu, Yun Zhang, Sanhu Gou* and Jingman Ni*, 
{"title":"Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides","authors":"Zufang Ba,&nbsp;Yu Wang,&nbsp;Yinyin Yang,&nbsp;Bingqian Ren,&nbsp;Beibei Li,&nbsp;Xu Ouyang,&nbsp;Jingying Zhang,&nbsp;Tingting Yang,&nbsp;Yao Liu,&nbsp;Yuhuan Zhao,&nbsp;Ping Yang,&nbsp;Xiaoyan Wu,&nbsp;Wenbo Mao,&nbsp;Chao Zhong,&nbsp;Hui Liu,&nbsp;Yun Zhang,&nbsp;Sanhu Gou* and Jingman Ni*,&nbsp;","doi":"10.1021/acs.jmedchem.4c0117910.1021/acs.jmedchem.4c01179","DOIUrl":null,"url":null,"abstract":"<p >Developing a straightforward and effective strategy to modify antimicrobial peptides (AMPs) is crucial in overcoming the challenges posed by their instability and toxicity. Phosphorylation can reduce toxicity and improve the stability of AMPs. Based on these, we designed a series of peptides and their corresponding phosphorylated forms. The results showed that all phosphorylated peptides displayed reduced toxicity and enhanced stability compared to their unphosphorylated counterparts. Among them, W<sub>3</sub>BipY<sub>8</sub>-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W<sub>3</sub>BipY<sub>8</sub> but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W<sub>3</sub>BipY<sub>8</sub>. W<sub>3</sub>BipY<sub>8</sub>-P exerted bactericidal effects by disrupting bacterial membranes. Notably, W<sub>3</sub>BipY<sub>8</sub>-P significantly prolonged the survival of bacteria-infected animals while its LD<sub>50</sub> was 4.2 times higher than that of W<sub>3</sub>BipY<sub>8</sub>. These findings highlight phosphorylation as an effective strategy for improving the antimicrobial properties of AMPs.</p>","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"67 21","pages":"18807–18827 18807–18827"},"PeriodicalIF":6.8000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c01179","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Developing a straightforward and effective strategy to modify antimicrobial peptides (AMPs) is crucial in overcoming the challenges posed by their instability and toxicity. Phosphorylation can reduce toxicity and improve the stability of AMPs. Based on these, we designed a series of peptides and their corresponding phosphorylated forms. The results showed that all phosphorylated peptides displayed reduced toxicity and enhanced stability compared to their unphosphorylated counterparts. Among them, W3BipY8-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W3BipY8 but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W3BipY8. W3BipY8-P exerted bactericidal effects by disrupting bacterial membranes. Notably, W3BipY8-P significantly prolonged the survival of bacteria-infected animals while its LD50 was 4.2 times higher than that of W3BipY8. These findings highlight phosphorylation as an effective strategy for improving the antimicrobial properties of AMPs.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
磷酸化是提高抗菌肽稳定性和降低其毒性的有效工具
要克服抗菌肽(AMPs)的不稳定性和毒性所带来的挑战,开发一种直接有效的策略来修饰抗菌肽(AMPs)至关重要。磷酸化可以降低抗菌肽的毒性并提高其稳定性。在此基础上,我们设计了一系列肽及其相应的磷酸化形式。结果表明,与未磷酸化的对应物相比,所有磷酸化肽都显示出毒性降低和稳定性增强的特点。其中,W3BipY8-P 是最有前途的多肽,其抗菌活性与其未磷酸化类似物 W3BipY8 相似,但溶血活性(降低了 19 倍)和细胞毒性(降低了 3.3 倍)显著降低,血清半衰期比 W3BipY8 延长了 6.3 倍。W3BipY8-P 通过破坏细菌膜发挥杀菌作用。值得注意的是,W3BipY8-P 能显著延长细菌感染动物的存活时间,而其半数致死剂量是 W3BipY8 的 4.2 倍。这些发现突出表明,磷酸化是提高 AMP 抗菌特性的一种有效策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry 医学-医药化学
CiteScore
4.00
自引率
11.00%
发文量
804
审稿时长
1.9 months
期刊介绍: The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents. The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.
期刊最新文献
Modular Assembly of Heterotrifunctional Molecules Enabled by Iodosulfonylation of Allenes and Subsequent Amination A Bifunctional Sulfide Donor Approach for Ischemic Stroke: Leveraging Butylphthalide as a Carrier for Sulfide Prodrug Discovery of Potent Kappa Opioid Receptor Agonists Derived from Akuammicine Advancements in NMDA Receptor-Targeted Antidepressants: From d-Cycloserine Discovery to Preclinical Efficacy of Lu AF90103. Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1